Loading...
Market
Will Ultragenyx Stock Price Increase by 20% by Aug 30, 2024?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Stock market data from reliable financial platforms like Bloomberg or Yahoo Finance
Story
Ultragenyx ($RARE) Gene Therapy for Rare Liver Ailment Succeeds in Late-Stage Trial
May 30, 2024, 08:51 PM
Ultragenyx's gene therapy for a rare liver ailment has succeeded in a late-stage trial. The therapy, which aims to treat a condition affecting the liver, has shown promising results, marking a significant milestone for the company. The news, reported on May 30, 2024, was covered by multiple sources, including Jason Mast for Stat News. Ultragenyx is listed under the ticker symbol $RARE.
View original story
Similar markets
Below $1 billion • 33%
$1 billion to $2 billion • 33%
Above $2 billion • 34%
Increase by over 20% • 33%
Increase by 10-20% • 33%
Increase by less than 10% • 34%
